Literature DB >> 31719951

The Effect of Deep Vein Thrombosis Prophylaxis on Bleeding in Periorbital Surgery in Trauma Patients.

Timothy Charles Woernley1, Blake Maida1, James Melville1, Jose Marchena1, Nagi Demian1.   

Abstract

The aim of this study is to assess if there is an increase in postoperative venous thromboembolism (VTE) or bleeding complications in patients who received perioperative chemical thromboprophylaxis compared with patients in whom chemical thromboprophylaxis was held during periorbital trauma surgery. This is a retrospective chart review of patients undergoing periorbital surgery treated in three different city hospitals, by the Department of Oral and Maxillofacial Surgery, University of Texas, between August 2014 and December 2016. A total of 237 patients were included in this study. None of these patients suffered a postoperative VTE. A total of 102 patients received perioperative pharmacologic thromboprophylaxis in the form of enoxaparin or heparin. In this group, one patient suffered a buccal space hematoma. Chemical thromboprophylaxis was held in 135 patients preoperatively and for at least 24 hours postoperatively. In this group, one patient suffered a retrobulbar hematoma after repair of an orbital floor fracture. The rate of postoperative bleeding complications was compared by the chi-square test and was not statistically significant ( p  = 0.8417). © Thieme Medical Publishers.

Entities:  

Keywords:  anticoagulation; midface; trauma; venous thromboembolism

Year:  2019        PMID: 31719951      PMCID: PMC6839977          DOI: 10.1055/s-0039-1683915

Source DB:  PubMed          Journal:  Craniomaxillofac Trauma Reconstr        ISSN: 1943-3875


  13 in total

1.  Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Michael K Gould; David A Garcia; Sherry M Wren; Paul J Karanicolas; Juan I Arcelus; John A Heit; Charles M Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Variability is the standard: the management of venous thromboembolic disease following trauma.

Authors:  Jesse Bandle; Steven R Shackford; Carol Beth Sise; M Margaret Knudson
Journal:  J Trauma Acute Care Surg       Date:  2014-01       Impact factor: 3.313

Review 3.  Low-molecular-weight heparins.

Authors:  J I Weitz
Journal:  N Engl J Med       Date:  1997-09-04       Impact factor: 91.245

4.  Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study.

Authors:  J A Heit; M D Silverstein; D N Mohr; T M Petterson; W M O'Fallon; L J Melton
Journal:  Arch Intern Med       Date:  2000-03-27

Review 5.  Thromboprophylaxis for trauma patients.

Authors:  Luis M Barrera; Pablo Perel; Katharine Ker; Roberto Cirocchi; Eriberto Farinella; Carlos Hernando Morales Uribe
Journal:  Cochrane Database Syst Rev       Date:  2013-03-28

6.  A potentially expanded role for enoxaparin in preventing venous thromboembolism in high risk blunt trauma patients.

Authors:  S H Norwood; C E McAuley; J D Berne; V L Vallina; D B Kerns; T W Grahm; J W McLarty
Journal:  J Am Coll Surg       Date:  2001-02       Impact factor: 6.113

7.  A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma.

Authors:  W H Geerts; R M Jay; K I Code; E Chen; J P Szalai; E A Saibil; P A Hamilton
Journal:  N Engl J Med       Date:  1996-09-05       Impact factor: 91.245

8.  Correlation of missed doses of enoxaparin with increased incidence of deep vein thrombosis in trauma and general surgery patients.

Authors:  Scott G Louis; Misa Sato; Travis Geraci; Ross Anderson; S David Cho; Philbert Y Van; Jeffrey S Barton; Gordon M Riha; Samantha Underwood; Jerome Differding; Jennifer M Watters; Martin A Schreiber
Journal:  JAMA Surg       Date:  2014-04       Impact factor: 14.766

9.  Orbital hemorrhage and compressive optic neuropathy in patients with midfacial fractures receiving low-molecular weight heparin therapy.

Authors:  Basem T Jamal; Robert J Diecidue; Daniel Taub; Allen Champion; Jurij R Bilyk
Journal:  J Oral Maxillofac Surg       Date:  2009-07       Impact factor: 1.895

10.  Thromboprophylaxis in surgical patients.

Authors:  Martin O'Donnell; Jeffrey I Weitz
Journal:  Can J Surg       Date:  2003-04       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.